These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 39424835)

  • 1. Effects of classical psychedelics on implicit and explicit emotional empathy and cognitive empathy: a meta-analysis of MET task.
    Olami A; Peled-Avron L
    Sci Rep; 2024 Oct; 14(1):24480. PubMed ID: 39424835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M; Meester M
    J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.
    Schipper S; Nigam K; Schmid Y; Piechotta V; Ljuslin M; Beaussant Y; Schwarzer G; Boehlke C
    Cochrane Database Syst Rev; 2024 Sep; 9(9):CD015383. PubMed ID: 39260823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.
    Leger RF; Unterwald EM
    J Psychopharmacol; 2022 Jan; 36(1):20-30. PubMed ID: 34519567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.
    Madrid-Gambin F; Fabregat-Safont D; Gomez-Gomez A; Olesti E; Mason NL; Ramaekers JG; Pozo OJ
    Biomed Pharmacother; 2023 Dec; 169():115775. PubMed ID: 37944438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.
    Varley TF; Carhart-Harris R; Roseman L; Menon DK; Stamatakis EA
    Neuroimage; 2020 Oct; 220():117049. PubMed ID: 32619708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics.
    Wilkes R; Roberts DM; Liknaitzky P; Brett J
    Clin Toxicol (Phila); 2024 Apr; 62(4):242-247. PubMed ID: 38753585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychedelics and mental health: a population study.
    Krebs TS; Johansen PØ
    PLoS One; 2013; 8(8):e63972. PubMed ID: 23976938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Psilocybin on Empathy and Moral Decision-Making.
    Pokorny T; Preller KH; Kometer M; Dziobek I; Vollenweider FX
    Int J Neuropsychopharmacol; 2017 Sep; 20(9):747-757. PubMed ID: 28637246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20
    Aday JS; Bloesch EK; Davoli CC
    J Psychoactive Drugs; 2019; 51(3):210-217. PubMed ID: 30836890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Brief Historical Overview of Psychedelic Research.
    Geyer MA
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 May; 9(5):464-471. PubMed ID: 38000715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.
    Wong S; Yu AY; Fabiano N; Finkelstein O; Pasricha A; Jones BDM; Rosenblat JD; Blumberger DM; Mulsant BH; Husain MI
    J Psychoactive Drugs; 2024; 56(4):513-529. PubMed ID: 37615379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.
    Goldberg SB; Shechet B; Nicholas CR; Ng CW; Deole G; Chen Z; Raison CL
    Psychol Med; 2020 Dec; 50(16):2655-2666. PubMed ID: 33143790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadening Your Mind to Include Others: The relationship between serotonergic psychedelic experiences and maladaptive narcissism.
    van Mulukom V; Patterson RE; van Elk M
    Psychopharmacology (Berl); 2020 Sep; 237(9):2725-2737. PubMed ID: 32472162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
    De Gregorio D; Enns JP; Nuñez NA; Posa L; Gobbi G
    Prog Brain Res; 2018; 242():69-96. PubMed ID: 30471683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-drug interactions involving classic psychedelics: A systematic review.
    Halman A; Kong G; Sarris J; Perkins D
    J Psychopharmacol; 2024 Jan; 38(1):3-18. PubMed ID: 37982394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.
    Dos Santos RG; Hallak JE; Baker G; Dursun S
    J Psychopharmacol; 2021 Apr; 35(4):453-458. PubMed ID: 33740877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.
    Calleja-Conde J; Morales-García JA; Echeverry-Alzate V; Bühler KM; Giné E; López-Moreno JA
    Addict Biol; 2022 Nov; 27(6):e13229. PubMed ID: 36301215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular insights into psychedelic drug action.
    Slocum ST; DiBerto JF; Roth BL
    J Neurochem; 2022 Jul; 162(1):24-38. PubMed ID: 34797943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.
    Yao Y; Guo D; Lu TS; Liu FL; Huang SH; Diao MQ; Li SX; Zhang XJ; Kosten TR; Shi J; Bao YP; Lu L; Han Y
    Psychiatry Res; 2024 May; 335():115886. PubMed ID: 38574699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.